D Ignatova1, Y-T Chang1, W Hoetzenecker2, E Guenova1. Show Affiliations » 1. Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. 2. Department of Dermatology, University Hospital Linz, Linz, Austria.
Abstract
Entities: Chemical Disease
Mesh： See more » Administration, CutaneousAntineoplastic Agents, Phytogenic/administration & dosageAntineoplastic Agents, Phytogenic/adverse effectsBiopsyDermatitis, Irritant/epidemiologyDermatitis, Irritant/etiologyDiterpenes/administration & dosageDiterpenes/adverse effectsEuphorbia/chemistryHumansMycosis Fungoides/complicationsMycosis Fungoides/diagnosisMycosis Fungoides/drug therapyMycosis Fungoides/pathologySeverity of Illness IndexSkin/drug effectsSkin/pathologySkin Neoplasms/complicationsSkin Neoplasms/diagnosisSkin Neoplasms/drug therapySkin Neoplasms/pathologyTreatment Outcome
Substances： See more » 3-ingenyl angelateAntineoplastic Agents, PhytogenicDiterpenes
Year: 2019 PMID： 31004508 DOI： 10.1111/bjd.18018
Source DB: PubMed Journal: Br J Dermatol ISSN： 0007-0963 Impact factor: 9.302